Welcome to Lundbeck!

Discussion in 'Alder Biopharmaceuticals' started by anonymous, Sep 16, 2019 at 6:46 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Did you still have the interview? If so what did the interviewers say?
     

  2. anonymous

    anonymous Guest

    I kinda believe in this post. Lundbeck reps may be good but they wouldn't know much, if anything, about bill to/send to purchasing accounts. They will need experienced account reps with infusion sales experience and B&B.
     
  3. anonymous

    anonymous Guest

    They’ve actively been looking for something for their neurology team to sell since Northera will be going generic in 2021. They’re not looking to build another sales team, they wanted something that would fit with their current sales team
     
  4. anonymous

    anonymous Guest


    All over the map, depending on when you got them. Lots over $25, some even over $50. Big disappointment.
     
  5. anonymous

    anonymous Guest

    I think all of these posts are just a guess. CP has a rep super negativity. There are so many ways this can go down. I'll wait to hear from the Alder people.
     
  6. anonymous

    anonymous Guest

    Actually there aren’t that many ways for this to go.

    If you have prior migraine or buy and bill, you might be kept over a poor performing Lundbeck psych rep.

    Putting a field force of any more than 200 after this is just foolish.

    As for the product, it is a niche opportunity at best for the clinics with an infusion suite. Biohaven will have an oral in about 18 months and three aggressive competitors with SC products will make this a near impossibility in the non specialist and PCP market.

    Lundbeck overpaid and they are going to need to make it up somehow. High goals, high price, high pressure and high turnover.
     
  7. anonymous

    anonymous Guest

    Are you an Alder rep?
     
  8. anonymous

    anonymous Guest

    B&B is not rocket science. Anyone can learn it. That’s why when the Alder mgmt was all, “Do you have buy and bill”? “How many years, how many products”? I knew they were clueless. If you have it, you have it. If you don’t, you can easily learn it!
     
  9. anonymous

    anonymous Guest

    I’m confused why people are in such denial. Lundbeck has two sales teams capable of selling this. They were looking for a late stage drug for their current sales team. Alder doesn’t even have a sales team! Why do people who were interviewing with Alder (that never even got a written offer!) think they’re in the running to take a Lundbeck rep’s job?! Move on
     
  10. anonymous

    anonymous Guest

    IDK. Could Lundbeck keep Alder as a wholly owned subsidiary? Other companies have done it. Might offer financial advantages. If Lundbeck does keep the MAB in house, then yes, the drug is doomed. The Vantage article is crap from a drug standpoint. This drug is a winner, but only in the right hands. Alder could do it. Lundbeck cannot.
     
  11. anonymous

    anonymous Guest

     
  12. Current Alder staff here - about as far from “sales” as one may be.

    The contrarians here neglect patient demand for epti, which is huge. Incentive pricing for clinicians is a foot in the door, but migraine suffers are going to be begging for this scrip. I wish Lundbeck sales staff all the best! Patients first. Selah.
     
  13. anonymous

    anonymous Guest

    did anyone else get the hiring freeze email from PO?
     
  14. anonymous

    anonymous Guest

    I got a call and email basically saying you’ll be contacted “if” after the deal closes they want to move forward. In my book that is their way of saying sorry for wasting your time...but move along now.
     
  15. anonymous

    anonymous Guest

    Bohaven will have their oral migraine out within 6 months not 18. Sorry for your luck.
     
  16. anonymous

    anonymous Guest

    Given that it hasn’t even filed yet, 6 months may be a bit on the optimistic side.

    Either way, this is a classic case of Lundbeck BD doing a deal just to do a deal.

    The commercial input was either non existent or ill informed.
     
  17. anonymous

    anonymous Guest

    Will they keep the managers at Alder and roll them in or are they gone too?
     
  18. anonymous

    anonymous Guest

    LMAO, Malleck leaves a long career at Amgen to join this hell hole. Karma baby!
     
  19. anonymous

    anonymous Guest

    All the Amgen losers that came over I love are getting the shaft.
     
  20. anonymous

    anonymous Guest

    There were comments about folks that got verbal offers last week and were expecting written ones. Did anyone get an offer for a field sales position? I have to say that I’ve been around for 25 years in our industry and I find it shady that Alder wasted so many people’s time prepping and flying to interviews only to say oops. It’s on hold. It’s not like one day they were putting together a sales force and they poof- the next day Lundbeck décides to drop
    2 billion